Since it has been reported that Nrf2 activity is negatively regulated by Keap1 [32], we investigated whether JNK1 affects the Keap1-dependent degradation of Nrf2 in QC-treated CRC cells. The gene discussed is NFE2L2; the disease is colorectal carcinoma.